CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-03 | Firmani Lori Interim CFO | Option exercise · Restricted Stock Units | −374 | 1,100 | ||
| 2025-06-18 | Dallas Jayson Donald Alexander Director | Grant or award · Stock Option (right to buy) | +720 | 720 | ||
| 2025-06-18 | Munshi Amit Director | Grant or award · Stock Option (right to buy) | +720 | 720 | ||
| 2025-06-18 | Shapiro David Director | Grant or award · Stock Option (right to buy) | +720 | 720 | ||
| 2025-06-18 | Prener Anne Director | Grant or award · Stock Option (right to buy) | +720 | 720 | ||
| 2025-06-18 | WECHSLER AMY B Director | Grant or award · Stock Option (right to buy) | +720 | 720 | ||
| 2025-06-18 | GOLDFISCHER CARL Director | Grant or award · Stock Option (right to buy) | +1,440 | 1,440 | ||
| 2025-01-03 | Winslow Garrett General Counsel | Option exercise | +1,320 | 1,480 | ||
| 2025-01-03 | Winslow Garrett General Counsel | Sale | −471 | $5.60 | $3K | 1,009 |
| 2025-01-03 | Winslow Garrett General Counsel | Option exercise · Restricted Stock Units | −1,320 | 2,680 | ||
| 2025-01-03 | Winslow Garrett General Counsel | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2025-01-03 | Firmani Lori Interim CFO | Option exercise | +726 | 726 | ||
| 2025-01-03 | Firmani Lori Interim CFO | Sale | −261 | $5.63 | $1K | 465 |
| 2025-01-03 | Firmani Lori Interim CFO | Option exercise · Restricted Stock Units | −726 | 1,474 | ||
| 2025-01-03 | Firmani Lori Interim CFO | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2025-01-03 | Kronmiller Matthew EVP Strategy and CBO | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2025-01-03 | Schambye Hans T. Chief Executive Officer | Option exercise | +2,640 | 4,738 | ||
| 2025-01-03 | Schambye Hans T. Chief Executive Officer | Sale | −1,341 | $5.60 | $8K | 3,397 |
| 2025-01-03 | Schambye Hans T. Chief Executive Officer | Option exercise · Restricted Stock Units | −2,640 | 5,360 | ||
| 2025-01-03 | Schambye Hans T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 |
Page 3 of 12 · 227 trades